Medspa Advertising & Claims Compliance Guide (FTC)

Before you claim anything—"reduces wrinkles by 50%," "results last 12 months," "FDA-approved for lip enhancement"—you must possess competent and reliable scientific evidence to back it up. The FTC's standard is not perfection; it's reasonable basis. For injectables and devices, this typically means peer-reviewed clinical studies, manufacturer data sheets, or real-world outcome data from your own practice (tracked systematically, not anecdotally). A single patient testimonial or influencer endorsement does not constitute substantiation. If you claim a specific duration (e.g., "Botox lasts 3–4 months"), you need data supporting that range. Manufacturer claims in package inserts and FDA summaries are generally safe to cite, but you cannot extrapolate beyond them. Many practices get into trouble by overstating results or timelines based on what they observe in their best patients rather than what evidence proves across populations. Document your substantiation file now—if the FTC requests it, you must produce it within 10 business days.

Before/after images are powerful marketing tools and also a primary FTC enforcement target. The rules are strict: photos must be representative of typical results, not cherry-picked best cases. If you show 10 before/afters, the FTC expects those to reflect the range of outcomes your patients actually achieve—not the top 10%. Lighting, angles, and makeup must be consistent between before and after shots; different lighting alone can exaggerate results. You must disclose any filters, editing, or post-processing. If results required multiple treatments (e.g., three filler sessions), that must be clearly stated near the image. Testimonials accompanying photos ("I love my new lips!") must be from real patients, and if results are not typical, you must disclose that. The FTC has brought cases against practices for using stock photos or heavily edited images. Best practice: photograph patients in standardized conditions, obtain written consent for use, and maintain a file linking each image to the patient record and treatment details.

Claiming your filler "lasts longer than Restylane" or your RF device "outperforms competitors" requires head-to-head evidence. You cannot rely on your own clinical impression or patient feedback; you need published comparative studies or robust internal data. The FTC scrutinizes comparative advertising closely because it can mislead consumers into thinking one product is objectively superior when the difference may be marginal or context-dependent. Avoid vague superiority language ("the best," "most advanced") without substantiation. If you reference a competitor by name, ensure your claim is precise and provable. For example, stating "Botox is FDA-approved for crow's feet; our toxin is not" is factually accurate and permissible. But claiming "our toxin works faster" requires clinical evidence. Stick to factual, substantiated comparisons or avoid the comparison altogether.

The FTC distinguishes between cosmetic claims and health/disease claims. Saying "smooths fine lines" is cosmetic; saying "treats hyperhidrosis" or "reduces migraine frequency" is a health claim and triggers stricter scrutiny. If you offer Botox for migraine, you can reference the FDA approval ("FDA-approved for chronic migraine") but cannot make additional health claims without strong evidence. Similarly, claiming a device "reduces cellulite" or "treats acne scars" requires substantiation; these straddle the cosmetic-medical line and invite regulatory attention. Avoid language like "heals," "cures," "treats," or "prevents" disease unless you have robust clinical data and the product is FDA-cleared for that indication. Stick to appearance-focused language: "improves the appearance of," "reduces the look of," "smooths." If you offer treatments for medical conditions (rosacea, melasma, psoriasis), ensure your marketing aligns with FDA clearance and clinical evidence, and consider consulting a healthcare attorney.

Patient testimonials and influencer endorsements must be honest, typical, and substantiated. If a patient says "my wrinkles disappeared," that's their subjective experience, but you cannot amplify it as proof of efficacy unless it reflects typical results. Influencers and paid endorsers must disclose their relationship with your practice (e.g., "#ad," "sponsored") clearly and conspicuously. The FTC has fined practices and influencers for undisclosed paid endorsements. If an influencer claims specific results ("I got 2 syringes and looked 10 years younger"), you are liable for that claim if you paid them or provided the treatment. Testimonials cannot claim results that are not typical; if you feature a patient who achieved exceptional results, you must disclose that. Collect written consent from patients before using their image or testimonial, and maintain records of any payments or free treatments given to endorsers. Social media posts are subject to the same FTC rules as traditional advertising.

You can accurately reference FDA clearances: "Botox is FDA-approved for glabellar lines," "Juvederm is cleared for lip augmentation." But do not overstate clearance scope. If a device is cleared for skin tightening but not cellulite reduction, you cannot claim it treats cellulite. Avoid phrases like "clinically proven" or "scientifically proven" unless you have robust, published evidence; FDA clearance alone does not constitute clinical proof of superiority. Do not imply that a product is FDA-approved for off-label uses (e.g., "FDA-approved Botox for jawline contouring" when Botox is not cleared for that indication). You can offer off-label treatments, but marketing them as FDA-approved is deceptive. Reference the FDA's official product labeling and clearance summaries; if you are uncertain about a claim, err on the side of caution or consult the FDA's website or a regulatory attorney. Misrepresenting clearance status is a common FTC violation.

The FTC actively monitors aesthetic practices through social media, online reviews, and consumer complaints. If you receive a warning letter or civil investigative demand (CID), respond promptly and completely; failure to do so can result in penalties. The FTC can seek injunctions, require corrective advertising, impose civil penalties up to $43,792 per violation (as of 2024), and in egregious cases, refer cases to state attorneys general or the Department of Justice. Practices have also faced private lawsuits from consumers claiming deceptive advertising. Audit your website, social media, and patient materials quarterly: remove unsubstantiated claims, ensure before/afters are representative, and verify that all testimonials are real and typical. Train staff on compliant messaging. If you work with a marketing agency or social media manager, ensure they understand FTC rules and include compliance language in contracts. Document your substantiation and maintain it for at least three years. Compliance is cheaper than litigation.